Evidence map›Paper›PMID 38225354›Full record

ArticleEMBO reports2024

Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth.

Laura R Diaz, Jon Gil-Ranedo, Karolina J Jaworek, Nsikan Nsek, Joao Pinheiro Marques, Eleni Costa, David A Hilton, Hubert Bieluczyk, Oliver Warrington, C Oliver Hanemann and 3 more

Open access · diamondAbstract read
In one paragraph

Article in EMBO reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Laura R Diaz *Peninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.
Jon Gil-Ranedo *Peninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.ORCID http://orcid.org/0000-0002-7365-3411
Karolina J JaworekPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.ORCID http://orcid.org/0009-0005-7268-5461
Nsikan NsekPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.ORCID http://orcid.org/0000-0003-4412-178X
Joao Pinheiro MarquesPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.ORCID http://orcid.org/0000-0003-0682-8784
Eleni CostaPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.
David A HiltonDepartment of Cellular and Anatomical Pathology, University Hospitals Plymouth, PL6 8DH, Plymouth, UK.
Hubert BieluczykPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.
Oliver WarringtonPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.
C Oliver HanemannPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.ORCID http://orcid.org/0000-0002-1951-1025
Matthias E FutschikSchool of Biomedical Sciences, Faculty of Health, Derriford Research Facility, University of Plymouth, PL6 8BU, Plymouth, UK.ORCID http://orcid.org/0000-0002-6245-8071
Torsten BossingPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK.ORCID http://orcid.org/0000-0002-3277-9130
Claudia S BarrosPeninsula Medical School, Faculty of Health, John Bull Building, University of Plymouth, PL6 8BU, Plymouth, UK. claudia.barros@plymouth.ac.uk.ORCID http://orcid.org/0000-0003-0361-0333
Peninsula College of Medicine and Dentistry · GBBangor University · GBDerriford Hospital · GBPlymouth Hospital · GBWellcome Centre for Human Neuroimaging · GB

Funding

Brain Research UK (BRUK) 201617-05Brain Tumour Research N/ATenovus (Tenovus Cancer Care) PhD2011/L39University of Plymouth N/A
6 · The paper itself

Abstract

Cell commitment to tumourigenesis and the onset of uncontrolled growth are critical determinants in cancer development but the early events directing tumour initiating cell (TIC) fate remain unclear. We reveal a single-cell transcriptome profile of brain TICs transitioning into tumour growth using the brain tumour (brat) neural stem cell-based Drosophila model. Prominent changes in metabolic and proteostasis-associated processes including ribogenesis are identified. Increased ribogenesis is a known cell adaptation in established tumours. Here we propose that brain TICs boost ribogenesis prior to tumour growth. In brat-deficient TICs, we show that this dramatic change is mediated by upregulated HEAT-Repeat Containing 1 (HEATR1) to promote ribosomal RNA generation, TIC enlargement and onset of overgrowth. High HEATR1 expression correlates with poor glioma patient survival and patient-derived glioblastoma stem cells rely on HEATR1 for enhanced ribogenesis and tumourigenic potential. Finally, we show that HEATR1 binds the master growth regulator MYC, promotes its nucleolar localisation and appears required for MYC-driven ribogenesis, suggesting a mechanism co-opted in ribogenesis reprogramming during early brain TIC development.

Indexed as

Brain NeoplasmsGlioblastomaMinor Histocompatibility AntigensProto-Oncogene Proteins c-mycRNA-Binding ProteinsAnimalsBrainCarcinogenesisCell Transformation, NeoplasticDNA-Binding ProteinsDrosophilaDrosophila ProteinsGliomaHumansNeoplastic Stem CellsDNA-Binding ProteinsDrosophila ProteinsHEATR1 protein, humanMinor Histocompatibility AntigensMYC protein, humanProto-Oncogene Proteins c-mycRNA-Binding ProteinsBrain TumourigenesisHEATR1MYCNeural Stem CellsRibogenesis

Identifiers

PMID38225354
PMCPMC10897169
OpenAlexW4390898345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.